Novartis Lifts FullYear Sales and Profit Outlook Amid Strong Operational Performance ixigo Partners with Uber and redBus to Enhance Train Travel Experience with Integrated Cab and Bus Bookings Escalating Geopolitical Tensions and Strong US Dollar Strain Asian Currency Reserves Flipkart Achieves RecordBreaking SingleDay Sales of 200 Million on Ecommerce Giants Largest Shopping Event Shell Capital Return Strategy Reemerges as Key Investor Focus Trumps AIGenerated Images of Greenland and Media Figures Stir Geopolitical and Market Chatter BRC Group Holdings RILYN Q1 2024 Earnings Net Loss of 171 per Share Reflects Ongoing Pressures Nuvalent Inc NUVL Q1 2026 Earnings Slightly Wider Loss No Revenue Yet as PreClinical Pipeline Progresses DLR Q1 2026 Earnings Slight EPS Beat Amid Steady Data Center Demand CECO Environmental Corp CECO Q1 2026 Earnings EPS Surges Past Estimates with 1395 Surprise MainStreet Bancshares Inc MNSB Q1 2026 Earnings Strong EPS Beat Surprises Analysts SUPV Q1 2026 Earnings Massive EPS Beat as Company Swings to Profitability CO2 Energy Transition Corp Warrant NOEMW Surges Over 24 Key Levels to Watch Intellia Therapeutics Slides Slightly Amid Cautious Trading in GeneEditing Sector Core AI Holdings CHAI Inches Higher as Support Near 108 Holds Firm Nuveen Municipal Credit Income Fund NZF Holds Steady Near Resistance as Income Seekers Eye Yield Array Digital Infrastructure 5500 Senior Notes Edge Higher Amid Steady Income Demand US Seeks to Expand American AI Integration in Asia Following TrumpXi Meeting Goldman Sachs Reportedly Selected as Lead Underwriter for SpaceX IPO Signaling Landmark Deal Fidelity Analysis Highlights Insurance Blind Spot Key Term vs Whole Life Tradeoffs Mortgage and Refinance Interest Rates Decline on May 23 2026 Rates Fall Across Key Loan Types Penny Stocks Rally 12 Surge Up to 125 in Two Months Two Turn Multibaggers Roth Capital Raises Price Target on The Beachbody Company Following Q1 Results Beneficient BENF Q1 2026 Earnings Massive EPS Beat on Positive Net Income but Shares Slide Inovio Pharmaceuticals Slips Below 130 as Selling Pressure Intensifies